{"id":"cc10d6c4-c494-498c-a42b-51626a59d58c","kind":"news","code":"cc10d6c4-c494-498c-a42b-51626a59d58c","name":"Xellar Biosystems raises RMB 200 million in Series A financing","nameBasis":"translated-title","summary":"On 2026-04-02, according to Xiniu Data, Xellar Biosystems completed Series A financing, raising RMB 200 million. Investors were lead investor Guoshouguquan, participating investor Jingtai Holdings, participating investor Yayi Capital, participating investor Junlian Capital. The company is an AI drug discovery platform.","description":"","country":null,"category":null,"originalName":"Xellar Biosystems完成A轮融资，金额2亿人民币","eventDate":"2026-04-02T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T17:18:21.138Z","englishUpdatedAt":"2026-10-20T18:23:00.769Z","reviewedAt":"2026-10-20T18:23:00.769Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"015ab68d0a09fbc5a494550ff48daf83d570b095983aea0481ed433684115ccb","companyId":"9b5cb888-cb53-4668-a01e-971156cae58a","foundedYear":null,"logoUrl":null,"originalText":"2026年4月2日，据烯牛数据报道，Xellar Biosystems完成A轮融资，金额2亿人民币。投资方为国寿股权领投、晶泰控股、雅亿资本、君联资本跟投。该公司为AI药物发现平台。","sources":[],"related":[{"id":"d6b33bd1-d0f0-4b4f-9290-d85a6dee1390","kind":"institutions","code":"UB-I8941","name":"Guoshouguquan","nameBasis":"transliterated","summary":"","description":"","country":null,"category":null,"originalName":"国寿股权","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T15:36:25.639Z","englishUpdatedAt":"2026-10-15T17:35:39.814Z","reviewedAt":"2026-10-15T17:35:39.814Z","snapshotAt":"2026-10-15T16:06:35.585Z","sourceHash":"9ed31108c9c94f4f55edccc02d96c9588a4ceae3ade81c15133c6219d0bc1e36","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/guoshouguquan"},{"id":"5d44f7d8-e050-4edf-81a8-26796c95eb45","kind":"institutions","code":"UB-I2271","name":"Jingtai Technology","nameBasis":"transliterated","summary":"XtalPi, a listed AI-driven drug discovery company expanding its biopharmaceutical ecosystem through strategic investments.","description":"XtalPi, a listed AI-driven drug discovery company expanding its biopharmaceutical ecosystem through strategic investments.","country":null,"category":null,"originalName":"晶泰科技","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:25.615Z","englishUpdatedAt":"2026-10-15T21:41:49.054Z","reviewedAt":"2026-10-15T21:41:49.054Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"54005a2e37edceafc1899569f3dae6fee18479ec05f12e2babd1d28c6dc44ba7","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/jingtai-technology"},{"id":"5b63233f-7b5f-41fd-bc75-ecd5171e4c0a","kind":"institutions","code":"UB-I2415","name":"Junlian Capital","nameBasis":"transliterated","summary":"A venture capital firm under Legend Holdings focused on startup- and growth-stage enterprise investments.","description":"A venture capital firm under Legend Holdings focused on startup- and growth-stage enterprise investments.","country":null,"category":null,"originalName":"君联资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:06:19.425Z","englishUpdatedAt":"2026-10-15T21:17:22.123Z","reviewedAt":"2026-10-15T21:17:22.123Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"9471bda3b1ecab0d5eb3a44b7a6a03f6a549a7f2258a424105f677dec8f8315c","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/junlian-capital"},{"id":"9b5cb888-cb53-4668-a01e-971156cae58a","kind":"companies","code":"UB-C7683","name":"Xellar Biosystems","nameBasis":"source-english","summary":"","description":"","country":"China","category":null,"originalName":"耀速科技Xellar Biosystems","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:25:26.452Z","reviewedAt":"2026-10-20T18:25:26.452Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"ea03b03c142e41303af1305b3d108291240d684ad74efb585edbb8b59e705a6b","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/xellar-biosystems"},{"id":"9192cff1-bbee-43de-be1d-180d07179cc6","kind":"institutions","code":"UB-I6135","name":"Yayi Capital","nameBasis":"transliterated","summary":"Yayi Capital is a Chinese venture capital firm, focused on investment in seed- to growth-stage startups.","description":"Yayi Capital is a Chinese venture capital firm, focused on investment in seed- to growth-stage startups.","country":null,"category":null,"originalName":"雅亿资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:29.006Z","englishUpdatedAt":"2026-10-15T18:26:24.994Z","reviewedAt":"2026-10-15T18:26:24.994Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"6ef266084b5495488d7ad790debd304b8083d3cbb3572f8e22ebf6ba583dc97b","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/yayi-capital"}],"path":"/news/cc10d6c4-c494-498c-a42b-51626a59d58c","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Xellar Biosystems","path":"/companies/xellar-biosystems"}},"canonical":"https://uniquebase.ai/news/cc10d6c4-c494-498c-a42b-51626a59d58c"}